Last reviewed · How we verify

NCT06220903

The Effect of Complex Decongestive Therapy in Patients With Lymphedema

Completed NA Last updated 25 January 2024
What this trial tests

NA trial testing Complex Decongestive Therapy in Lymphedema in 20 participants. Completed in 30 June 2019.

Timeline
1 September 2018
Primary endpoint
30 June 2019
30 June 2019

Quick facts

Lead sponsorMedipol University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 September 2018
Primary completion30 June 2019
Estimated completion30 June 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Medipol University

Who can join

Adults 30 to 60, female only, with Lymphedema or Urine Marking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate objectively the effect of lymphatic fluid which is circulated with Complex Decongestive Therapy on fluid excretion from the body in patients with lymphedema.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Complex Decongestive Therapy

Trials testing the same drug.

Other recruiting trials for Lymphedema

Currently open trials in the same condition.

Other Medipol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06220903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing